Tuberculosis and Legionella pneumophila pneumonia in a patient receiving anti-tumour necrosis factor-alpha (anti-TNF-alpha) treatment

Clin Microbiol Infect. 2007 Oct;13(10):1036-7. doi: 10.1111/j.1469-0691.2007.01796.x. Epub 2007 Aug 17.

Authors

G Mancini, L Erario, R Gianfreda, A Oliva, A P Massetti, C M Mastroianni, V Vullo

PMID: 17711485
DOI: 10.1111/j.1469-0691.2007.01796.x

No abstract available

Publication types

Case Reports
Comment
Letter

MeSH terms

Adult
Anti-Inflammatory Agents / adverse effects*
Anti-Inflammatory Agents / therapeutic use
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal / therapeutic use
Behcet Syndrome / drug therapy*
Behcet Syndrome / immunology
Humans
Infliximab
Legionnaires' Disease* / immunology
Legionnaires' Disease* / microbiology
Male
Tuberculosis, Pulmonary* / immunology
Tuberculosis, Pulmonary* / microbiology
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal
Tumor Necrosis Factor-alpha
Infliximab